Analysis of induced pluripotent stem cells from a BRCA1 mutant family.
Analysis of induced pluripotent stem cells from a BRCA1 mutant family.
复制标题
DOI:
10.1016/j.stemcr.2013.08.004
复制
发表时间:
2013
影响因子:
5.9
通讯作者:
Ross, Theodora S.
中科院分区:
文献类型:
--
作者:
Soyombo, Abigail A.;Wu, Yipin;Kolski, Lauren;Rios, Jonathan J.;Rakheja, Dinesh;Chen, Alice;Kehler, James;Hampel, Heather;Coughran, Alanna;Ross, Theodora S.
Understanding BRCA1 mutant cancers is hampered by difficulties in obtaining primary cells from patients. We therefore generated and characterized 24 induced pluripotent stem cell (iPSC) lines from fibroblasts of eight individuals from a BRCA1 5382insC mutant family. All BRCA1 5382insC heterozygous fibroblasts, iPSCs, and teratomas maintained equivalent expression of both wild-type and mutant BRCA1 transcripts. Although no difference in differentiation capacity was observed between BRCA1 wild-type and mutant iPSCs, there was elevated protein kinase C-theta (PKC-theta) in BRCA1 mutant iPSCs. Cancer cell lines with BRCA1 mutations and hormone-receptor-negative breast cancers also displayed elevated PKC-theta. Genome sequencing of the 24 iPSC lines showed a similar frequency of reprogramming-associated de novo mutations in BRCA1 mutant and wild-type iPSCs. These data indicate that iPSC lines can be derived from BRCA1 mutant fibroblasts to study the effects of the mutation on gene expression and genome stability. Induced pluripotent stem cell (iPSC) lines from a BRCA1 mutant family were made BRCA1 was elevated in iPSC lines compared with progenitor fibroblast lines Protein kinase C-theta was elevated in mutant iPSCs and ER-negative breast cancer Increased de novo mutations were found in only one BRCA1 mutant iPSC line Twenty-four induced pluripotent stem cell (iPSC) lines were generated from a BRCA1 mutant family. Protein kinase C-theta (PKC-theta) was elevated in BRCA1 mutant compared to wild-type iPSC lines. PKC-theta was also increased in ER-negative breast cancers. A bioinformatic filter using the genome sequence of lymphoblasts, fibroblasts, and iPSCs from each patient identified reprogramming-associated de novo mutations. Increased mutation numbers were found in one of the BRCA1 mutant iPSC lines and none of the wild-type iPSC lines.
登录
查看更多内容
影响因子:
56.9
作者:
FUTREAL, PA;LIU, QY;WISEMAN, R
通讯作者:
WISEMAN, R
影响因子:
8
作者:
Belguise, K.;Milord, S.;Chalbos, D.
通讯作者:
Chalbos, D.
影响因子:
4.8
作者:
Horwitz, AA;Sankaran, S;Parvin, JD
通讯作者:
Parvin, JD
DOI:
10.1093/jnci/djm207
发表时间:
2007-11-21
期刊:
Journal of the National Cancer Institute
影响因子:
--
作者:
Hosey AM;Gorski JJ;Murray MM;Quinn JE;Chung WY;Stewart GE;James CR;Farragher SM;Mulligan JM;Scott AN;Dervan PA;Johnston PG;Couch FJ;Daly PA;Kay E;McCann A;Mullan PB;Harkin DP
通讯作者:
Harkin DP
影响因子:
46.9
作者:
Chambers, Stuart M.;Fasano, Christopher A.;Papapetrou, Eirini P.;Tomishima, Mark;Sadelain, Michel;Studer, Lorenz
通讯作者:
Studer, Lorenz